Extra vaccines should be available to the immunocompromised in the next few days, with a question added about immune status before all vaccinations.
Author: Karen Weintraub, USA TODAY
FDA authorizes COVID-19 vaccine boosters for the immunocompromised
People with suppressed immune systems may not have gotten adequate protection from initial doses of COVID vaccine and may need a booster, FDA says.
Delta variant substantially more contagious than other variants, CDC presentation warns
Evidence is mounting about the dangers of the delta variant and how mask-wearing is essential to bring it under control, according to a CDC memo.
Breakthrough COVID infections after vaccination can lead to long-haul symptoms, Israeli study shows
The findings raise questions about the coronavirus vaccines’ protection and suggest that even vaccinated people could experience long-term symptoms.
The fourth wave of COVID-19 cases is here. Will we escape the UK’s fate? It’s too soon to know.
COVID-19 may not be as deadly in this new wave, because older people are largely vaccinated and younger people are less likely to die.
Do you need a booster shot for COVID-19? It’s not recommended, yet. Here’s what to know.
Vaccine companies are studying the effectiveness of a third COVID-19 shot, known as a booster. Here’s what you need to know.
Mask guidelines are getting confusing if you’re vaccinated against COVID. Experts break down the details.
CDC Director Rochelle Walensky and other experts say people vaccinated against COVID are protected, but local officials may decide masks are needed.
‘It isn’t over for us’: For those with weakened immune systems, COVID-19 vaccines don’t mean the end of the pandemic
For those with compromised immune systems, health experts say ‘get vaccinated, act unvaccinated,’ as vaccines may not protect well against COVID-19.
The same mRNA technology used in COVID-19 vaccines could help treat cancer
Fighting COVID-19 proved a boon to cancer research. Here’s how scientists are using the same mRNA technology to attack tumors.
Johnson & Johnson COVID-19 vaccine protects against virus variants, study shows
In the new study, Harvard researchers who developed the J&J COVID-19 vaccine found it protected against severe disease regardless of the variant.